Form 4: Gevo Chief Business Officer Paul Bloom Receives Significant Equity Grant

Gevo, Inc.'s Chief Business Officer, Paul D. Bloom, was granted 210,084 shares of restricted common stock and 626,618 stock options on June 9, 2025, as part of his compensation.

Summary

• Paul D. Bloom, Chief Business Officer of Gevo, Inc., acquired 210,084 shares of restricted common stock on June 9, 2025, at a price of $0 per share.
• These restricted shares will vest in three equal annual installments, starting one year from the grant date, contingent on his continuous service with Gevo.
• Additionally, Mr. Bloom was granted 626,618 stock options on June 9, 2025, with an exercise price of $1.18 per share and an expiration date of June 8, 2035.
• These stock options also vest in three equal annual installments, beginning on the first anniversary of the grant date, subject to his continuous service.
• Following these transactions, Mr. Bloom directly beneficially owns 1,070,500 shares of common stock and 626,618 stock options.
• He also indirectly owns 22,064.71 shares of common stock through a 401(k) Plan.

Sentiment

Score: 7

Explanation: The filing indicates a significant equity grant to a key executive, which is generally a positive sign for executive retention and alignment of interests with shareholders. While there's potential for future dilution, it's a standard compensation practice. The grant itself doesn't indicate immediate financial distress or exceptional performance, but rather ongoing executive incentive.

Positives

• The grant of restricted stock and stock options aligns the Chief Business Officer's interests with long-term shareholder value, incentivizing continued performance and retention.
• The equity awards represent a significant component of executive compensation, indicating confidence in the executive's role and future contributions to the company.

Negatives

• The issuance of new equity awards, particularly stock options, could lead to potential dilution for existing shareholders if the options are exercised in the future.
• The $0 price for restricted stock grants means the company is issuing shares without direct cash inflow for those specific shares, though it's a common form of compensation.

Risks

• The vesting of both restricted stock and stock options is contingent on the reporting person's continuous service, meaning the benefits are forfeited if employment ceases before vesting.
• The value of the stock options is dependent on the future market price of Gevo's common stock exceeding the exercise price of $1.18.

Future Outlook

The document indicates future vesting schedules for the equity awards, contingent on continuous service, suggesting an expectation of the executive's continued tenure and contribution to the company's performance over the next three years.

Industry Context

This filing reflects standard executive compensation practices within publicly traded companies, where equity grants like restricted stock and stock options are used to incentivize long-term performance and align management interests with shareholders. For companies in the renewable fuels or biotechnology sector like Gevo, attracting and retaining key talent through competitive compensation packages, including equity, is crucial for driving innovation and strategic growth.

Comparison to Industry Standards

• The use of restricted stock and stock options as a significant component of executive compensation is a common practice across various industries, including renewable energy and biotechnology, aligning executive incentives with long-term company performance.
• The vesting schedule of three equal annual installments is a typical structure for such equity grants, designed to encourage executive retention and sustained contribution over several years.
• The exercise price of $1.18 for the stock options is set at or above the market price on the grant date, which is standard for incentive stock options, requiring stock price appreciation for the options to be "in the money."

Related Party Transactions

• The equity grant to Paul D. Bloom, an officer of Gevo, Inc., constitutes a related party transaction, as it involves compensation from the company to a key executive.

Stakeholder Impact

• Shareholders: Potential for future dilution if stock options are exercised, but also benefit from incentivized executive performance and retention.
• Employees: May signal stability and a commitment to retaining key talent within the company.
• Management: The grants provide significant long-term incentives and compensation, aligning their financial interests with the company's success.

Next Steps

• The restricted common stock and stock options will begin vesting in three equal annual installments starting on the first anniversary of the grant date (June 9, 2025), contingent on Paul D. Bloom's continuous service.

Key Dates

Recommendation

Keywords

Gevo, GEVO, Paul D. Bloom, Chief Business Officer, CBO, SEC Form 4, insider transaction, restricted stock, stock options, equity grant, executive compensation, beneficial ownership